graph Evidence gap map comparisons
atezolizumab based treatmentpembrolizumab based treatment
atezolizumab alone atezolizumab plus cometinib pembrolizumab alone
Comparator:  vs Standard of Care (SoC);   vs regorafenib; 
Risk of bias:  low;   some concerns;   high;  NA;